Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedFeb 16, 2025
DataAggregated Company Financials
Companies5
  • 7D5.8%
  • 3M3.7%
  • 1Y-6.5%
  • YTD-1.3%

In the last week, the Biotech industry is up 5.8%, with Genmab up 8.6%. In the past year, the industry is down 6.5%. Earnings are forecast to grow by 21% annually.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 16 Feb 2025DKK 162.8bDKK 27.7bDKK 7.8b12x20.8x5.9x
Tue, 14 Jan 2025DKK 164.7bDKK 26.0bDKK 4.7b17.4x35.1x6.3x
Thu, 12 Dec 2024DKK 172.2bDKK 26.0bDKK 4.7b17.8x36.7x6.6x
Sat, 09 Nov 2024DKK 178.0bDKK 26.0bDKK 4.3b22.2x41.4x6.8x
Mon, 07 Oct 2024DKK 173.9bDKK 25.5bDKK 5.5b21.6x31.8x6.8x
Wed, 04 Sep 2024DKK 202.3bDKK 25.5bDKK 5.5b25x37x7.9x
Fri, 02 Aug 2024DKK 205.1bDKK 24.8bDKK 5.6b18.8x36.4x8.3x
Sun, 30 Jun 2024DKK 188.2bDKK 24.8bDKK 5.6b17x33.4x7.6x
Tue, 28 May 2024DKK 179.3bDKK 24.8bDKK 5.6b18.6x31.8x7.2x
Thu, 25 Apr 2024DKK 179.0bDKK 23.9bDKK 5.0b18.6x35.5x7.5x
Sat, 23 Mar 2024DKK 193.4bDKK 23.9bDKK 5.0b19.8x38.5x8.1x
Mon, 19 Feb 2024DKK 173.5bDKK 22.8bDKK 4.2b23.6x41.1x7.6x
Wed, 17 Jan 2024DKK 173.9bDKK 23.3bDKK 4.2b24.3x41.8x7.5x
Fri, 15 Dec 2023DKK 176.4bDKK 23.3bDKK 4.2b25.9x42.4x7.6x
Sun, 12 Nov 2023DKK 168.3bDKK 22.7bDKK 4.3b21.3x39.2x7.4x
Tue, 10 Oct 2023DKK 188.7bDKK 22.0bDKK 4.7b22x39.8x8.6x
Thu, 07 Sep 2023DKK 197.4bDKK 22.0bDKK 4.7b23.1x41.8x9x
Sat, 05 Aug 2023DKK 190.1bDKK 20.6bDKK 3.9b36.7x49.1x9.2x
Mon, 03 Jul 2023DKK 198.3bDKK 19.5bDKK 4.4b41x45x10.1x
Wed, 31 May 2023DKK 209.5bDKK 19.5bDKK 4.4b41.2x47.6x10.7x
Fri, 28 Apr 2023DKK 207.8bDKK 17.9bDKK 4.1b32.5x50.7x11.6x
Sun, 26 Mar 2023DKK 194.8bDKK 17.9bDKK 3.5b30.5x55x10.9x
Tue, 21 Feb 2023DKK 210.1bDKK 14.7bDKK 3.3b32x64.2x14.3x
Thu, 19 Jan 2023DKK 209.3bDKK 14.7bDKK 3.3b31.7x64x14.2x
Sat, 17 Dec 2022DKK 225.3bDKK 14.7bDKK 3.3b35.3x68.8x15.3x
Mon, 14 Nov 2022DKK 223.3bDKK 14.7bDKK 3.5b34.6x64.4x15.2x
Wed, 12 Oct 2022DKK 201.9bDKK 12.4bDKK 1.5b44.8x132.9x16.3x
Fri, 09 Sep 2022DKK 204.7bDKK 12.4bDKK 1.5b45.5x137.5x16.5x
Sun, 07 Aug 2022DKK 201.3bDKK 11.1bDKK 130.5m70.3x1543x18.2x
Tue, 05 Jul 2022DKK 175.8bDKK 11.1bDKK 130.5m64.7x1347.3x15.9x
Thu, 02 Jun 2022DKK 154.6bDKK 11.0b-DKK 88,588,000.0057.4x-1745.6x14x
Sat, 30 Apr 2022DKK 177.5bDKK 10.7bDKK 622.4m54.5x285.2x16.6x
Mon, 28 Mar 2022DKK 171.3bDKK 10.7bDKK 625.7m51.7x273.7x16x
Wed, 23 Feb 2022DKK 150.9bDKK 10.4bDKK 252.9m44.7x596.6x14.5x
Price to Earnings Ratio

596.6x


Total Market Cap: DKK 150.9bTotal Earnings: DKK 252.9mTotal Revenue: DKK 10.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 105.7x202320242025
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 20.8x which is lower than its 3-year average PE of 106x.
  • The 3-year average PS ratio of 10.8x is higher than the industry's current PS ratio of 5.9x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 214% per year over the last three years.
  • Revenues for these companies have grown 39% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market-5.27%
Healthcare-9.20%
Biotech5.81%
Biotech5.81%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GMAB GenmabDKK 1.50k8.6%
+DKK 7.6b		-24.4%PE12.2x
ZEAL Zealand PharmaDKK 753.003.4%
+DKK 1.7b		55.3%PS692x
STRAP Strategic PartnersDKK 839.606.2%
+DKK 2.0m		-35.4%PB2.2x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BAVA

DKK 171.10

Bavarian Nordic

7D

-2.5%

1Y

6.1%

STRAP

DKK 839.60

Strategic Partners

7D

6.2%

1Y

-35.4%

GMAB

DKK 1,504.00

Genmab

7D

8.6%

1Y

-24.4%

BIOPOR

DKK 1.51

BioPorto

7D

-2.7%

1Y

-28.3%

ZEAL

DKK 753.00

Zealand Pharma

7D

3.4%

1Y

55.3%

Analysts Just Made A Substantial Upgrade To Their Zealand Pharma A/S (CPH:ZEAL) Forecasts

Dec 22
Analysts Just Made A Substantial Upgrade To Their Zealand Pharma A/S (CPH:ZEAL) Forecasts